Drawing for PEDIATRIC INFLUENZA LEADERSHIP FORUM

USPTO serial 97668718

PEDIATRIC INFLUENZA LEADERSHIP FORUM

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MCMORROW, JANICE LEE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with PEDIATRIC INFLUENZA LEADERSHIP FORUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nancy Sabarra

Nancy Sabarra FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 WEST 42ND ST., 17TH FL.NEW YORK, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
035Promoting awareness of influenza immunization and vaccination programs; providing business consulting and consumer information services related to pharmaceuticals and vaccines; providing a website for practice management and administrative support services to healthcare providers, medical professionals, and pharmacies; providing online information for healthcare providers, medical professionals, and pharmacies about practice management and administrative support related to pharmaceuticals and vaccines; business management consultation in the field of leadership developmentACTIVE—
041Educational services in the nature of seminars in the fields of leadership, medicine, pharmaceuticals, vaccines, and influenza and distribution of educational materials in connection therewith; leadership training programs in the fields of medicine, pharmaceuticals, vaccines, and influenza and distribution of educational materials in connection therewith; arranging and conducting conferences and meetings in the fields of leadership, medicine, pharmaceuticals, vaccines, and influenzaACTIVE—
042Pharmaceutical research and development; medical research services; providing medical and scientific research in the fields of pharmaceuticals, vaccines, and influenza; providing information in the fields of pharmaceutical and vaccine research and development and influenza research; providing a website featuring information in the fields of pharmaceutical and vaccine research and influenza research; consulting services related to research and development of medicines, pharmaceuticals, and vaccines; technical consulting in the field of pharmaceutical studiesACTIVE—
044Medical services; health care services; medical information services; providing a website with medical information in the fields of influenza and the prophylactic and therapeutic properties of pharmaceuticals and vaccines; providing medical information in the fields of influenza and the prophylactic and therapeutic properties of pharmaceuticals and vaccines; pharmaceutical consultation; consulting services relating to the prophylactic and therapeutic properties of vaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 16, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 13, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 20, 2026EXT5SOU EXTENSION 5 FILED—
Feb 28, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 17, 2026EX4GSOU EXTENSION 4 GRANTED—
Feb 17, 2026EXT4SOU EXTENSION 4 FILED—
Feb 17, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 27, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 26, 2025EX3GSOU EXTENSION 3 GRANTED—
Aug 26, 2025EXT3SOU EXTENSION 3 FILED—
Aug 26, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 26, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 25, 2025EX2GSOU EXTENSION 2 GRANTED—
Feb 25, 2025EXT2SOU EXTENSION 2 FILED—
Feb 25, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 26, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 26, 2024EX1GSOU EXTENSION 1 GRANTED—
Aug 26, 2024EXT1SOU EXTENSION 1 FILED—
Aug 26, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 27, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 2, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 2, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 13, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 24, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 22, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 21, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 21, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 18, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 22, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 15, 2023DOCKASSIGNED TO EXAMINER—
Feb 21, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Feb 21, 2023ALIEASSIGNED TO LIE—
Dec 15, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 30, 2022MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 29, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 11, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance